Latest S-1 registration statements

Silexion Therapeutics is launching a best-efforts offering to raise up to $5 million for advancing its RNAi-based cancer therapies.

Cosmos Health Inc. amends its S-1 filing, outlining a proposed $7.5 million offering and providing updates on its financial condition and recent transactions.

FreeCast, Inc. files an amendment to its S-1 registration statement for a direct listing of its Class A common stock on the Nasdaq Capital Market, involving the resale of up to 18,006,057 shares by existing shareholders.

Toppoint Holdings Inc. is proceeding with its IPO, offering 2,500,000 shares of common stock with an estimated price range of $4.00 to $6.00 per share.

Wellgistics Health, a holding company focused on pharmaceuticals and healthcare services, has filed an amendment to its Form S-1 registration statement for an initial public offering of 900,000 shares of common stock, with plans to list on the Nasdaq Capital Market under the symbol WGRX.

Brag House Holdings, Inc. files an amendment to its S-1 registration statement, detailing its business model, financial data, and growth prospects as it prepares for its initial public offering.

Stellar V Capital Corp., a blank check company, has filed an amendment to its S-1 registration statement for a $150 million initial public offering aimed at pursuing a business combination.

AleAnna, Inc. seeks to raise capital through the potential exercise of public warrants, while navigating a stock price below the exercise threshold and inherent market risks.

Lennar Corporation is set to spin off its land asset management business, Millrose Properties, into an independent, publicly traded REIT through a taxable distribution of shares to existing Lennar stockholders.

Hennessy Capital Investment Corp. VII, a newly formed blank check company, aims to raise $175 million through an IPO to target a business combination in the industrial technology and energy transition sectors.

Firefly Neuroscience is registering for resale 2,559,645 shares of common stock by selling securityholders, including shares from private placements, warrant exercises, and conversions.

ConnectM Technology Solutions has filed a registration statement for the potential resale of up to 51.7 million shares of its common stock and various warrants by existing security holders.

Marwynn Holdings, a supply chain company focused on food, beverage, and home improvement products, seeks to raise capital through an initial public offering.

Allurion Technologies is seeking to raise capital through an offering of common stock, pre-funded warrants, and common stock purchase warrants.

Venture Global, a rapidly growing LNG company, files for an IPO to support its continued expansion and capitalize on the increasing global demand for liquefied natural gas.

Flowco Holdings Inc. announces its initial public offering to fund growth in production optimization, artificial lift, and methane abatement solutions.

FibroBiologics has filed an amendment to its registration statement for the resale of up to 41,489,581 shares of common stock by YA II PN, LTD.

Sharps Technology Inc. plans to offer up to 6,726,457 units, each including common stock and warrants, or pre-funded units as an alternative.

Aclarion Inc. is set to offer shares of common stock along with Series A and B warrants, and pre-funded warrants in a new public offering.

Aspargo Labs, a specialty pharmaceutical and med-tech company, has filed an amendment to its Form S-1 registration statement for a direct listing on the NYSE, aiming to improve patient outcomes through innovative drug delivery systems.

Coeptis Therapeutics files an S-1 registration statement for the resale of up to 3,919,349 shares of common stock by selling stockholders, including shares issuable under a Standby Equity Purchase Agreement with Yorkville.

Expectation Acquisition Corporation, a blank check company, files an amendment to its Form S-1 registration statement for a $60 million initial public offering.

Veea Inc. files an amendment to its Form S-1 registration statement, detailing an equity line of credit agreement with White Lion Capital and recent business developments.

Veea Inc. has filed an amendment to its S-1 registration statement to allow for the resale of common stock and warrants by existing security holders.

Metsera, a clinical-stage biotech, is going public to fund its innovative pipeline of injectable and oral NuSH analog peptides targeting obesity and overweight, seeking to overcome limitations of existing treatments.

Nexalin Technology has filed an amendment to its S-1 registration statement to allow selling stockholders to resell up to 2,798,613 shares of common stock.

Reliance Global Group launches a unit offering, including common stock or pre-funded warrants and warrants, to finance the acquisition of Spetner Associates and for general corporate purposes.

New Era Helium Inc. has filed a registration statement for the resale of 50.8 million shares of common stock and 230,746 private warrants by existing shareholders.

Live Oak Acquisition Corp. V, a blank check company, has filed for a $200 million IPO to pursue a merger, share exchange, asset acquisition, or similar business combination.

Applied DNA Sciences has filed an amendment to its Form S-1 registration statement, pertaining to the resale of up to 41,640,625 shares of common stock issuable upon the exercise of outstanding warrants.